SARS-COV-2 Antigen Rapid Test Kit Nasal Swab COVID 19 Antigen Rapid Test Cassette
Brand Name:Citest
Certification:CE
Model Number:INCP-502-N
Minimum Order Quantity:N/A
Delivery Time:2-4 Weeks
Place of Origin:-
Contact Now
Add to Cart
Verified Supplier
Location:
Hangzhou Zhejiang
Address:
170-422, Richards Street, Vancouver BC V6B 2Z4, CANADA
Supplier`s last login times:
within 28 hours
Shipping
lt's easy to get a shipping quote! Just click the button below and complete the short form.
Get Shipping Quote
Product Details
Company Profile
Product Details
SARS-CoV-2 Antigen Rapid Test (Nasal Swab), COVID 19 Antigen Rapid Test Kit
SARS-CoV-2 Antigen Rapid Test (Nasal swab) is a rapid
chromatographic immunoassay for the qualitative detection of
SARS-CoV-2 nucleocapsid protein antigens present in nasal swab
specimen. For professional in vitro diagnostic use only
| Product features | Parameters |
| Principle | Chromatographic Immunoassay |
| Format | Cassette |
| Specimen | Oral fluid/Nasopharyngeal Swab/Nasal Swab |
| Certificate | CE |
| Reading Time | 15 minutes |
| Pack | 20 T |
| Storage Temperature | 2-30°C |
| Shelf Life | 2 Years |
INTENDED USE
The SARS-CoV-2 Antigen Rapid Test (Nasal Swab) is a rapid
chromatographic immunoassay for the qualitative detection of
SARS-CoV-2 nucleocapsid protein antigens in nasal swab specimen
from individuals with suspected SARS-CoV-2 infection in conjunction
with clinical presentation and the results of other laboratory
tests.
Results are for the detection of SARS-CoV-2 Antigens. An antigen is
generally detectable in upper respiratory specimens during the
acute phase of infection. Positive results indicate the presence of
viral antigens, but clinical correlation with patient history and
other diagnostic information is necessary to determine infection
status. Positive results do not rule out bacterial infection or
co-infection with other viruses. The agent detected may not be the
definite cause of disease.
Negative results do not preclude SARS-CoV-2 infection and should
not be used as the sole basis for treatment or patient management
decisions. Negative results should be treated as presumptive and
confirmed with a molecular assay, if necessary for patient
management. Negative results should be considered in the context of
a patient’s recent exposures, history and the presence of clinical
signs and symptoms consistent with COVID-19.
PRECAUTIONS
1. This package insert must be read completely before performing
the test. Failure to follow directions in package insert may yield
inaccurate test results.
2. For professional in vitro diagnostic use only. Do not use after
expiration date.
3. Do not eat, drink or smoke in the area where the specimens or
kits are handled.
4. Do not use test if pouch is damaged.
5. Handle all specimens as if they contain infectious agents.
Observe established precautions against microbiological hazards
throughout in the collection, handling, storage and disposal of
patient samples and used kit contents.
6. Wear protective clothing such as laboratory coats, disposable
gloves and eye protection when specimens are assayed.
7. Wash hands thoroughly after handling.
8. Please ensure that appropriate amounts of samples are used for
testing. Too much or too little sample size may lead to deviation
of results.
9. Viral Transport Media (VTM) may affect the test result;
extracted specimens for PCR tests cannot be used for the test.
10.The used test should be discarded according to local
regulations.
11.Humidity and temperature can adversely affect results.
SPECIMEN PREPARATION
Only the extraction buffer and tubes provided in the kit is to be
used for swab specimen preparation.
Please refer to the Procedure card for detailed information of
Specimen Extraction.
1. Place the swab specimen in the Extraction tube with Extraction
buffer. Rotate the swab for 10-15 seconds while pressing the head
against the inside of the tube to release the antigen in the swab.
2. Remove the swab while squeezing the swab head against the inside
of the Extraction tube as you remove it to expel as much liquid as
possible from the swab. Discard the swab in accordance with your
biohazard waste disposal protocol.
*NOTE: The storage of the specimen after extraction is stable for 2
hours at room temperature or 24 hours at 2-8 °C.
Nasal swab specimen Collection
1. Insert a sterilized swab less than one inch (about 2 cm) into a
nostril (until resistance is met at the turbinates).
2. Rotate the swab 5-10 times against the nasal wall. Using the
same swab repeat the collection procedure with the second nostril.
3. Withdraw the sterile swab; avoid excess volume and high-viscous
nasal discharge.
Caution: If the swab stick breaks during specimen collection,
repeat specimen collection with a new swab.
Specimen Transport and Storage Specimens should be tested as soon
as possible after collection. If swabs are not been processed
immediately, it is highly recommended the swab sample is placed
into a dry, sterile and tightly sealed plastic tube for storage.
The swab specimen in dry and sterile condition is stable for up to
24 hours at 2-8 °C.
DIRECTIONS FOR USE
Allow the test, extracted specimen and/or controls to equilibrate
to room temperature (15-30°C) prior to testing.
1. Remove the test cassette from the sealed foil pouch and use it
within one hour. Best results will be obtained if the test is
performed immediately after opening the foil pouch.
2. Invert the specimen extraction tube and add 3 drops of extracted
specimen (approx.75-100μl) to the sample well(S) and then start the
timer.
3. Wait for the colored line(s) to appear. Read the result at 15
minutes. Do not interpret the result after 20 minutes.
Limitation of Detection
The SARS-CoV-2 Antigen Rapid Test (Nasal swab) can detect out
SARS-CoV-2 heat-inactivated virus strain as low as 1X102 TCID50/ml.
SARS-COV-2 Antigen Rapid Test Kit Nasal Swab COVID 19 Antigen Rapid Test Cassette
Inquiry Cart
0